Roth Mkm Increases Monogram Orthopaedics (NASDAQ:MGRM) Price Target to $5.40

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) had its price target hoisted by investment analysts at Roth Mkm from $4.00 to $5.40 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Roth Mkm's price objective would indicate a potential upside of 69.81% from the stock's current price.

Separately, Roth Capital upgraded shares of Monogram Orthopaedics to a "strong-buy" rating in a research note on Monday, December 9th.

Monogram Orthopaedics Price Performance

Shares of NASDAQ MGRM traded up $0.06 during mid-day trading on Tuesday, hitting $3.18. 120,670 shares of the company's stock traded hands, compared to its average volume of 288,617. The company has a market capitalization of $112.22 million, a P/E ratio of -6.77 and a beta of 1.66. Monogram Orthopaedics has a 1 year low of $1.82 and a 1 year high of $4.90. The company's 50-day moving average is $2.62 and its two-hundred day moving average is $2.51.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last issued its earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.03. Equities analysts anticipate that Monogram Orthopaedics will post -0.49 EPS for the current fiscal year.

Remove Ads

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC purchased a new position in Monogram Orthopaedics during the fourth quarter worth about $25,000. Wells Fargo & Company MN lifted its stake in Monogram Orthopaedics by 286.6% during the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company's stock worth $27,000 after purchasing an additional 8,597 shares during the last quarter. Barclays PLC acquired a new position in Monogram Orthopaedics during the third quarter worth approximately $29,000. Orion Portfolio Solutions LLC purchased a new position in shares of Monogram Orthopaedics during the fourth quarter worth about $31,000. Finally, State Street Corp acquired a new position in shares of Monogram Orthopaedics during the third quarter worth about $62,000. 0.45% of the stock is owned by hedge funds and other institutional investors.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.